As a pioneer at the forefront of brain disorders for more than 60 years, Lundbeck is committed to developing and providing innovative therapies that help improve the quality of life of patients. This is important work because the burden of neurological and psychiatric disorders remains substantial. When we assess a medical condition, we see the person behind the disease and how it affects the lives of patients, their families, their caregivers and their communities.

What sets us apart:

Research: A deep pipeline – 100 percent targeted to brain disorders – in challenging areas like depression and anxiety, psychosis, epilepsy, Alzheimer’s disease and stroke.

Patients: A passion for patients that binds us together and drives us to act with urgency to address unmet medical needs today and into the future.

Partnerships: A long history of successful and diverse partnerships at all stages of a product’s lifecycle.